Wallaby Medical Raises over $20M in Series B+ Financing to Accelerate Development of its Innovative Stroke Solution Portfolio

The new funding will promote the development of a global hemorrhagic and ischemic stroke treatment product portfolio, as well as support the company’s two ongoing clinical trials.